New Pharmacological Perspectives and Therapeutic Potential of PPAR-&ggr; Agonists

E-ISSN： 1873-4286|10|28|3505-3524

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.28, 2004-11, pp. : 3505-3524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR-&ggr; Agonists as Regulators of Microglial Activation and Brain Inflammation

Current Pharmaceutical Design, Vol. 12, Iss. 1, 2006-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

PPAR- agonists: therapeutic role in diabetes, inflammation and cancer

By Murphy G.J. Holder J.C.

Trends in Pharmacological Sciences, Vol. 21, Iss. 12, 2000-12 ,pp. : 469-474

Elsevier

Access to resources Recommend Favorite

Measuring biomarkers to assess the therapeutic effects of PPAR agonists?

By Chinetti-Gbaguidi Giulia Staels Bart

Pharmacogenomics, Vol. 8, Iss. 11, 2007-11 ,pp. : 1567-1580

Future Medicine

Access to resources Recommend Favorite

Phytoestrogens: Pharmacological and Therapeutic Perspectives

Current Drug Targets, Vol. 4, Iss. 1, 2003-01 ,pp. : 77-87

Bentham Science Publishers

Access to resources Recommend Favorite